PMID- 26025665 OWN - NLM STAT- MEDLINE DCOM- 20160218 LR - 20181113 IS - 1476-5586 (Electronic) IS - 1522-8002 (Print) IS - 1476-5586 (Linking) VI - 17 IP - 5 DP - 2015 May TI - Presence of insulin-like growth factor binding proteins correlates with tumor-promoting effects of matrix metalloproteinase 9 in breast cancer. PG - 421-33 LID - S1476-5586(15)00047-0 [pii] LID - 10.1016/j.neo.2015.04.003 [doi] AB - The stroma of breast cancer can promote the disease's progression, but whether its composition and functions are shared among different subtypes is poorly explored. We compared stromal components of a luminal [mouse mammary tumor virus (MMTV)-Neu] and a triple-negative/basal-like [C3(1)-Simian virus 40 large T antigen (Tag)] genetically engineered breast cancer mouse model. The types of cytokines and their expression levels were very different in the two models, as was the extent of innate immune cell infiltration; however, both models showed infiltration of innate immune cells that expressed matrix metalloproteinase 9 (MMP9), an extracellular protease linked to the progression of many types of cancer. By intercrossing with Mmp9 null mice, we found that the absence of MMP9 delayed tumor onset in the C3(1)-Tag model but had no effect on tumor onset in the MMTV-Neu model. We discovered that protein levels of insulin-like growth factor binding protein-1 (IGFBP-1), an MMP9 substrate, were increased in C3(1)-Tag;Mmp9(-/-) compared to C3(1)-Tag;Mmp9(+/+) tumors. In contrast, IGFBP-1 protein expression was low in MMTV-Neu tumors regardless of Mmp9 status. IGFBP-1 binds and antagonizes IGFs, preventing them from activating their receptors to promote cell proliferation and survival. Tumors from C3(1)-Tag;Mmp9(-/-) mice had reduced IGF-1 receptor phosphorylation, consistent with slower tumor onset. Finally, gene expression analysis of human breast tumors showed that high expression of IGFBP mRNA was strongly correlated with good prognosis but not when MMP9 mRNA was also highly expressed. In conclusion, MMP9 has different effects on breast cancer progression depending on whether IGFBPs are expressed. CI - Copyright (c) 2015 The Authors. Published by Elsevier Inc. All rights reserved. FAU - Park, Jae-Hyun AU - Park JH AD - Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA. FAU - Rasch, Morten Gronbech AU - Rasch MG AD - Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA; The Finsen Laboratory, Rigshospitalet, Copenhagen N, Denmark. FAU - Qiu, Jing AU - Qiu J AD - Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA. FAU - Lund, Ida Katrine AU - Lund IK AD - The Finsen Laboratory, Rigshospitalet, Copenhagen N, Denmark. FAU - Egeblad, Mikala AU - Egeblad M AD - Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA; University of California, San Francisco, San Francisco, CA, USA. Electronic address: egeblad@cshl.edu. LA - eng GR - R01 CA057621/CA/NCI NIH HHS/United States GR - R01CA057621/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Neoplasia JT - Neoplasia (New York, N.Y.) JID - 100886622 RN - 0 (Antigens, Viral, Tumor) RN - 0 (IGFBP1 protein, human) RN - 0 (Insulin-Like Growth Factor Binding Protein 1) RN - EC 3.4.24.35 (MMP9 protein, human) RN - EC 3.4.24.35 (Matrix Metalloproteinase 9) SB - IM MH - Animals MH - Antigens, Viral, Tumor MH - Breast Neoplasms/metabolism/*pathology MH - Disease Models, Animal MH - Disease Progression MH - Female MH - Humans MH - Immunohistochemistry MH - Insulin-Like Growth Factor Binding Protein 1/*biosynthesis MH - Kaplan-Meier Estimate MH - Mammary Neoplasms, Experimental/metabolism/pathology MH - Mammary Tumor Virus, Mouse MH - Matrix Metalloproteinase 9/*biosynthesis MH - Mice MH - Mice, Knockout MH - Polyomavirus Infections MH - Protein Array Analysis MH - Retroviridae Infections MH - Simian virus 40 MH - Triple Negative Breast Neoplasms/metabolism/pathology MH - Tumor Virus Infections PMC - PMC4468371 EDAT- 2015/05/31 06:00 MHDA- 2016/02/19 06:00 PMCR- 2015/05/27 CRDT- 2015/05/31 06:00 PHST- 2014/12/23 00:00 [received] PHST- 2015/03/30 00:00 [revised] PHST- 2015/04/09 00:00 [accepted] PHST- 2015/05/31 06:00 [entrez] PHST- 2015/05/31 06:00 [pubmed] PHST- 2016/02/19 06:00 [medline] PHST- 2015/05/27 00:00 [pmc-release] AID - S1476-5586(15)00047-0 [pii] AID - 10.1016/j.neo.2015.04.003 [doi] PST - ppublish SO - Neoplasia. 2015 May;17(5):421-33. doi: 10.1016/j.neo.2015.04.003.